2016-10-11T13:28:20-05:00 2015-12-31 ERNST & YOUNG US LLP 1401 MCKINNEY SUITE 1200 HOUSTON TX 77010 990 2015-01-01 741809687 Gulf Coast Regional Blood Center % ERIC EATON GULF 7137916203 1400 LA CONCHA LANE HOUSTON TX 77054 ERIC EATON CFO 2016-10-10 Maureen Foley P00177502 7137501500 2015 2017-02-10 21:41:12Z Eric Eaton 1400 La Concha Lane Houston TX 77054 102134880 false X WWW.GIVEBLOOD.ORG X 1974 TX TO MAINTAIN AND SUPPORT A REGIONAL BLOOD CENTER TO PRIMARILY SERVICE THE NEEDS OF THE PATIENTS AND DONORS IN THE AREAS WE SERVE. 24 22 808 210 0 0 143249 286800 95931556 90896432 393922 411734 618899 525266 97087626 92120232 49000 23000 0 0 43248544 42690257 0 0 2716 48117334 47175980 91414878 89889237 5672748 2230995 93520183 94939142 14094278 13392906 79425905 81546236 X TO MAINTAIN AND SUPPORT A REGIONAL BLOOD CENTER TO PRIMARILY SERVICE THE NEEDS OF THE PATIENTS AND DONORS IN THE AREAS WE SERVE. false false 71559802 23000 78200448 TRANSFUSION SERVICES - GULF COAST REGIONAL BLOOD CENTER COLLECTED OVER 310,000 UNITS OF BLOOD AND BLOOD COMPONENTS FROM VOLUNTARY DONORS. WE SHIPPED MORE THAN 325,000 UNITS TO AREA HOSPITALS AND SURGICAL CENTERS. IN 2015, GULF COAST REGIONAL BLOOD CENTER RECEIVED $333,788 OF IN-KIND CONTRIBUTIONS IN SUPPORT OF ITS PROGRAMS. THIS SUPPORT IS IN ADDITION TO THE $78,200,448 OF REVENUE SHOWN ABOVE. 9858052 10772865 THE BLOOD CENTER PERFORMS 13 DIFFERENT TESTS ON EVERY UNIT OF BLOOD COLLECTED. OUR CONSULTATION AND REFERENCE LABORATORY SERVE AS A COMPATIBILITY TESTING SERVICE AND PROVIDES SUITABLE, SAFE AND EFFECTIVE BLOOD AND BLOOD COMPONENTS FOR TRANSFUSION TO PATIENTS IN OVER 100 FACILITIES. THE LABORATORY ALSO FUNCTIONS AS A REFERENCE LABORATORY FOR CLIENTS AND AREA HOSPITALS PERFORMING AND EVALUATING A WIDE VARIETY OF TESTS TO RESOLVE COMPLEX SEROLOGICAL PATIENT PROBLEMS. CONSULTATION AND REFERENCE ALSO REGISTERS RARE DONORS WITH THE AMERICAN RARE DONOR PROGRAM (ARDP) AND PROVIDES AND RECEIVES RARE UNITS THROUGH ARDP. 1254712 1425678 THE MISSION OF THE NATIONAL MARROW DONOR PROGRAM (NMDP) IS TO EDUCATE AND REGISTER DONORS FOR THE NMDP REGISTRY, TO PROMOTE THE AWARENESS OF THE LIFE SAVING NEED FOR MARROW AND PERIPHERAL BLOOD DONATIONS FROM ADULT DONORS TO PATIENTS AWAITING TRANSPLANT, AND TO RAISE FUNDS FOR DONOR TESTING, TYPING AND RECRUITMENT. 455199 497441 83127765 true true false false false false false false false false true false false false false true false true false false false false false false true false false false true true true false false false false false false false false false false false false false false false true true false false false true 23 0 true 808 true false false false false false true true false false false false X 24 22 false false false false false false false true true false false true true true true true true true true true true X ERIC EATON 7137916203 1400 LA CONCHA LANE Houston TX 77054 X Greg Bernica Treasurer 2.0 0.0 X X 0 0 0 Arthur Bracey MD Trustee 1.0 0.0 X 0 0 0 Robert S Craig Trustee 1.0 0.0 X 0 0 0 William H Fleming III MD Trustee 1.0 0.0 X 0 0 0 A Tomas Garcia MD Trustee 1.0 0.0 X 0 0 0 Richard J Hausner MD Trustee 1.0 0.0 X 0 0 0 Alexander Indrikovs MD Trustee 1.0 0.0 X 0 0 0 Russell W H Kridel MD Trustee 1.0 0.0 X 0 0 0 Kenneth L Mattox MD Trustee 1.0 0.0 X 0 0 0 Khush Nariman Trustee 1.0 0.0 X 0 0 0 Ethan A Natelson MD Trustee 1.0 0.0 X 0 0 0 Bradford S Patt MD Trustee 1.0 0.0 X 0 0 0 Darrell W Reese Trustee 1.0 0.0 X 0 0 0 Duane K Rossmann Trustee 1.0 0.0 X 0 0 0 Linda B Russell Trustee 1.0 0.0 X 0 0 0 James G Slack Trustee 1.0 0.0 X 0 0 0 Michael E Speer MD Trustee 1.0 0.0 X 0 0 0 Elizabeth Torres MD Trustee 1.0 0.0 X 0 0 0 Rick Townsend Trustee 1.0 0.0 X 0 0 0 David Yawn MD Trustee 1.0 0.0 X 0 0 0 Brian Gannon President and CEO 50.0 0.0 X X 511964 0 48618 Susan N Rossmann MD Chief Medical Officer 50.0 0.0 X X 344284 0 36377 Kimberly E Monday MD Trustee 1.0 0.0 X 0 0 0 David M McClanahan Chairman 5.0 0.0 X X 0 0 0 Karen Tellepsen Vice Chairman 2.0 0.0 X X 0 0 0 John D Milam MD Secretary 2.0 0.0 X X 0 0 0 Melissa Fisher Chief Financial Officer 50.0 0.0 X 256134 0 36230 Caron Cousins-Baker Chief Technical Officer 50.0 0.0 X 259776 0 31732 Doug McClain Chief Info & Donor SVCS 1.0 0.0 X 72199 0 362 Granville C Betton Vice President Operations 50.0 0.0 X 216567 0 7967 Elizabeth Hartwell MD Director of Medical Services 50.0 0.0 X 275678 0 26920 Barton Block Director of MIS 50.0 0.0 X 162016 0 20231 Gretchen Sassone Director of Human Resources 50.0 0.0 X 147929 0 16468 Marc Lewis Director, Product Management 50.0 0.0 X 144418 0 30150 Cheri Jennings Director of Technical Services 50.0 0.0 X 140456 0 20278 Theresa L Pina Director, Recruitment & Mobile 50.0 0.0 X 140616 0 20365 Stephen C Ruth Director, Business Development 50.0 0.0 X 136842 0 25451 2808879 0 321149 26 false true false Ernst Young LLP 3712 Solutions Center Chicago IL 60677 Audit - Tax Services 109475 1 211009 75791 0 286800 SERVICE FEES, BLOOD & BLOOD COMPONENTS 621990 78200448 78200448 0 0 Laboratory Services 621500 10772865 10772865 0 0 NATIONAL MARROW DONOR FEES AND CONTRIB 621990 1425678 1425678 0 0 Cellular Therapies fees 621990 497441 497441 0 0 90896432 359886 359886 0 0 0 0 0 9885000 45898 9874932 4118 10068 41780 51848 51848 44342 211009 135598 -91256 -91256 0 0 Other Misc. Revenue 900099 466795 466795 0 Purchase Rebates 900099 149727 149727 0 616522 92120232 91512954 0 320478 0 0 23000 23000 0 0 0 0 1660926 892827 768099 0 0 0 0 0 32877088 31044518 1832570 0 2204537 1967230 237307 0 3599909 3321269 278640 0 2347797 2201088 146709 0 0 0 0 0 69475 0 69475 0 110000 0 110000 0 0 0 0 0 0 0 0 0 0 0 209887 43134 166753 5415925 5412362 3563 0 1651380 948297 700367 2716 1292270 1253688 38582 0 0 0 0 0 2569917 2111364 458553 0 532371 522503 9868 0 0 0 0 0 174743 152818 21925 0 51907 0 51907 0 0 0 0 0 3370023 2842842 527181 0 1322375 0 1322375 0 Collection and lab supply 15104261 15102771 1490 0 Reagents 11209341 11209341 0 0 Marrow Donor Program 1254712 1254712 0 0 Imported Blood Components 78181 78181 0 0 2759212 2745820 13392 89889237 83127765 6758756 2716 0 16458319 9494821 3760722 9502379 0 0 9527289 9915752 0 0 0 0 0 0 5539795 5032304 1102649 1026365 63278740 39471945 25156803 23806795 30892443 35096629 0 0 0 0 0 0 1082163 1064097 93520183 94939142 9323642 9146125 0 0 83943 83944 4638812 4132204 0 0 0 0 47881 30633 0 0 0 0 14094278 13392906 X 79420320 81540636 5585 5600 0 0 79425905 81546236 93520183 94939142 2230995 -110664 0 0 0 X false true X true false X 171985 121021 216583 143249 286800 939638 103961467 102086614 99557018 96596584 91512954 493714637 0 0 0 104133452 102207635 99773601 96739833 91799754 494654275 0 0 0 494654275 147408 190203 178449 277036 359866 1152962 27000 0 27000 147408 190203 178449 304036 359866 1179962 0 0 0 104280860 102397838 99952050 97043869 92159620 495834237 0.99762 0.99812 0.00238 0.00188 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 4017891 4017891 0 26185066 12250199 13934867 0 3398733 3120519 278214 0 29278133 24101227 5176906 0 398917 0 398917 23806795 0 0 X 92494849 -110664 333788 151493 374617 92120232 0 0 92120232 90358623 333788 135598 469386 89889237 0 0 89889237 SCHEDULE D, PART X, LINE 2 THE BLOOD CENTER IS EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(A) OF THE INTERNAL REVENUE CODE AS AN ORGANIZATION DESCRIBED IN SECTION 501(C)(3). THE BLOOD CENTER IS ALSO EXEMPT FROM STATE INCOME TAXES. HOWEVER, FEDERAL TAXES MAY BE DUE IN THE EVENT NET INCOME IS DERIVED FROM ACTIVITIES UNRELATED TO THE ORGANIZATION'S CHARITABLE PURPOSE. NO SUCH NET INCOME IS KNOWN TO EXIST DURING 2015 OR 2014. ACCORDINGLY, NO PROVISION FOR INCOME TAXES HAS BEEN REFLECTED IN THE CONSOLIDATED FINANCIAL STATEMENTS. THE BLOOD CENTER HAS NOT IDENTIFIED OR RECORDED ANY LIABILITY FOR UNCERTAIN TAX POSITIONS FOR 2015 OR 2014. Form 990, Schedule D, Part XI, Line 2d OTHER RECONCILING ITEMS FORM 990 TO AFS Fundraising Expense: $135,598 Net Assets Released from Restrictions: $ 15,895 ----------- TOTAL $151,493 Form 990, Schedule D, Part XII, Line 2d OTHER RECONCILING ITEMS FORM 990 TO AFS FUNDRAISING EXPENSE: $135,598 ---------- TOTAL $135,598 NMDP Roll Dice 143866 115524 28342 8339 2859 30208 5030 6885 NMDP MMFL Golf 111485 95485 16000 8457 6973 3040 63807 0 255351 211009 44342 16796 9832 33248 5030 70692 135598 -91256 true H.S. AND BLOOD BANK SCHOLARSHIPS 23 23000 Form 990, Schedule I DESCRIPTION OF ORGANIZATION'S PROCEDURES FOR MONITORING THE USE OF GRANTS ARE TO PROMOTE RESEARCH AND DEVELOPMENT IN ALL SCIENTIFIC, MEDICAL/TECHNICAL AND ADMINISTRATIVE ASPECTS OF BLOOD BANKING; INCLUDING BUT NOT LIMITED TO IMMUNOHEMATOLOGY, TRANSFUSION THERAPY, TISSUE TYPING AND RELATED ACTIVITIES. PROGRESS REPORTS OF RESEARCH ACCOMPLISHED SHOULD BE COMPREHENSIVE AND INDICATE THE SIGNIFICANCE OF THE STUDY/RESEARCH. THE PROGRESS REPORTS SHOULD INCLUDE AN ACCOUNTING OF MONIES SPENT IN THE PERFORMANCE OF THE RESEARCH AND SHOULD BE PRESENTED IN THE PRESCRIBED FORMAT. REPORTS OF UNPUBLISHED RESEARCH ARE CONFIDENTIAL. DEADLINES FOR PROGRESS REPORTS ARE AS FOLLOWS: ONE GRANT FUNDED (NO RENEWAL) JANUARY 15TH OF THE FOLLOWING FUNDING YEAR. COMPETITIVE RENEWAL GRANTS MUST ACCOMPANY GRANT RENEWAL APPLICATION. IF PROGRESS REPORTS ARE NOT RECEIVED PRIOR TO THE JANUARY MEETING OF GULF COAST REGIONAL BLOOD CENTER'S BOARD OF TRUSTEES, GCRBC HAS THE RIGHT TO TERMINATE THE GRANT AND RECLAIM ANY UNUSED FUNDS. X true true X X X false true false false false true false false false Brian Gannon President and CEO 391291 0 102531 0 18142 0 40597 0 8021 0 560582 0 0 0 Melissa Fisher Chief Financial Officer 212780 0 27951 0 15403 0 28209 0 8021 0 292364 0 0 0 Susan N Rossmann MD Chief Medical Officer 283982 0 39214 0 21088 0 31108 0 5269 0 380661 0 0 0 Caron Cousins-Baker Chief Technical Officer 213766 0 29471 0 16539 0 27171 0 4561 0 291508 0 0 0 Elizabeth Hartwell MD Director of Medical Services 248016 0 25072 0 2590 0 21506 0 5414 0 302598 0 0 0 Barton Block Director of MIS 146589 0 15214 0 213 0 18039 0 2192 0 182247 0 0 0 Gretchen Sassone Director of Human Resources 132858 0 13657 0 1414 0 16280 0 188 0 164397 0 0 0 Marc Lewis Director, Product Management 130604 0 13620 0 194 0 16645 0 13505 0 174568 0 0 0 Cheri Jennings Director of Technical Services 125948 0 13305 0 1203 0 15717 0 4561 0 160734 0 0 0 Granville C Betton Vice President Operations 215238 0 168 0 1161 0 0 0 7967 0 224534 0 0 0 Theresa L Pina Director, Recruitment & Mobile 127473 0 12050 0 1093 0 12868 0 7497 0 160981 0 0 0 Stephen C Ruth Director, Business Development 122220 0 13074 0 1548 0 15437 0 10014 0 162293 0 0 0 FORM 990, SCHEDULE J, PART I, LINE 1a GROSS UP PAYMENTS ARE PROVIDED ON VEHICLE ALLOWANCE AND VEHICLE USE FOR EXECUTIVES. FORM 990, SCHEDULE J, PART I, LINE 3 ALL EXECUTIVE COMPENSATION IS REVIEWED AND APPROVED BY THE COMPENSATION COMMITTEE AND THE BOARD. COMPENSATION AMOUNTS ARE DETERMINED BASED ON INDEPENDENT SURVEYS AND COMPARABLE DATA TO ORGANIZATIONS OUR SIZE FOR NON-PROFITS, OTHER BLOOD CENTERS, AND GENERAL INDUSTRY. THIS PROCESS WAS LAST UNDERTAKEN FROM DECEMBER 2014 THROUGH JANUARY 2015. ALL OTHER MANAGEMENT POSITIONS' (DIRECTORS) COMPENSATION ARE BASED ON COMPENSATION REVIEWS PERFORMED BY OUR HUMAN RESOURCES DEPARTMENT. THE HR DEPARTMENT OBTAINS INDEPENDENT SURVEYS FOR THESE POSITIONS AND OTHER COMPARABLE DATA TO DETERMINE THEIR RECOMMENDATION OF THE COMPENSATION. ALL SALARY RECOMMENDATIONS ARE REVIEWED AND APPROVED BY THE EXECUTIVES. THIS PROCESS WAS LAST UNDERTAKEN FROM DECEMBER 2014 THROUGH FEBRUARY 2015. FORM 990, SCHEDULE J, PART I, LINE 4b THE CEO AND CMO PARTICIPATE IN AN EXECUTIVE DEFERRED COMPENSATION (457F) NONVESTED PLAN. CONTRIBUTIONS TO THE PLAN FOR THE CEO AND CMO FOR 2015 WERE $7,653 AND $0, RESPECTIVELY. FORM 990, SCHEDULE J, PART I, LINE 6 ALL EMPLOYEES PARTICIPATE IN A BONUS PLAN THAT IS DEPENDENT ON ACHIEVING COMPANY-WIDE GOALS. ONE GOAL IS TIED TO NET REVENUES OVER EXPENSES. SOME EXECUTIVES ALSO HAVE INDIVIDUAL GOALS THAT IMPACT BONUS PLAN AMOUNTS. PAY OUT PERCENTAGES FOR EXECUTIVES ARE SET BY THE COMPENSATION COMMITTEE AND ARE APPROVED BY THE COMPENSATION COMMITTEE AND BOARD PRIOR TO PAYMENT FOR ALL EXECUTIVES. A Hackberry Cultural Educ Facilities Finance Corp 752237898 2007-12-14 8100000 construct mobile operation complex false false false A 3967796 0 8246684 0 0 0 120882 0 0 7694325 431477 0 2009 false false true true A false false true false false 0 false false false true A false false true true true false 0 false 0 false true A true Schedule K, Part II, Line 3 total proceeds of issue includes original issue of $8,100,000 plus investment interest of $146,684. Schedule K, Part II, Line 10 Unspent proceeds in the amount of $431,477 were used to pay down the loan principal balance after all construction activities were complete. Total construction expense for the project was $9,218,000. However, the blood center was able to pay for approximately $1,500,000 from our own funds. As a result, we had excess loan funds on-hand and those funds $431,477 were used to pay down the principal balance of the debt in November 2009. schedule k, part iii, lines 3a & 3B Examples of the organization's service contracts are for janitorial, security and other incidental services. These contracts are excluded from private business use under the provisions of Regulation 1.141-3 as being solely incidental to the functions of a financed facility. None of these contracts include incentive or profit based compensation. Payments are for services provided only. No legal review is performed for such contracts as there are no private business use consequences. Schedule K, Part IV, Line 2 NO REBATE DUE. CALCULATED IN DECEMBER 2008. Tax Exempt funds were expended as intended within 23 months of the date of issuance. see explanation for schedule k, part ii, line 10. Schedule K, Part III, Line 9, Part IV, Line 7, and Part V The CFO and Director of Business Operations are knowledgeable of the rules and regulations associated with tax exempt bonds and monitor all activities that would have an impact on compliance with the use of those proceeds. gULF cOAST rEGIONAL bLOOD cENTER HAS FORMALLY ADOPTED WRITTEN procedures that outline the post closing requirements of tax exempt bonds and actions necessary to timely correct any violations. Any identification of violations, would be discussed with executive management and management would determine the best approach to correcting and reporting the violation. Schedule K, Part V The CFO and Director of Business Operations are aware of the requirements of tax exempt funds. Both are critical in the review and approval of all Gulf Coast Regional Blood Center contracts and specifically look for areas that would jeopardize those requirements. If a contract is entered into that results in private business use, the CFO would recommend corrective actions and timelines. The CFO and Director of Business Operations would report any violations through Voluntary Closing Agreement Program, if applicable. FORM 990, PART III, LINE 4D THERAPEUTIC APHERESIS SERVICES - THE BLOOD CENTER PERFORMS SPECIALIZED CELLULAR COLLECTIONS BY APHERESIS FOR PATIENTS WITH SPECIFIC TYPES OF CANCERS, INFECTIOUS DISEASES, AND AUTOIMMUNE DISORDERS. THE COLLECTED PRODUCTS ARE FURTHER MODIFIED BY BIOMEDICAL COMPANIES FOR REINFUSION TO THE PATIENTS AS A MEANS OF DISEASE TREATMENT OR DEVELOPMENT OF NOVEL THERAPEUTICS AND ADVANCED TREATMENT REGIMENS. FORM 990, PART VI, LINE 11B GULF COAST REGIONAL BLOOD CENTER'S (GCRBC) FINANCE COMMITTEE IS THE PRIMARY GOVERNING BODY RESPONSIBLE FOR THE OVERSIGHT OF GCRBC'S AUDITED FINANCIAL STATEMENTS, 990 AND 990-T TAX RETURNS. THE DRAFT TAX RETURNS, ONCE REVIEWED AND APPROVED BY MANAGEMENT, ARE PROVIDED TO THE FINANCE COMMITTEE FOR THEIR REVIEW AND THEY ARE DISCUSSED WITH MANAGEMENT. ONCE THE FINANCE COMMITEE APPROVES THE DRAFT TAX RETURNS, COPIES OF THE ENTIRE DRAFT TAX RETURNS ARE PROVIDED TO THE ENTIRE BOARD OF TRUSTEES PRIOR TO THE FILING OF THE TAX RETURNS. THE FINANCE COMMITTEE ACTS ON BEHALF OF THE FULL BOARD. THE FINANCE COMMITTEE CHAIR WILL REPORT ON THE REVIEW OF THE DRAFT TAX RETURNS TO THE FULL BOARD OF TRUSTEES. FORM 990, PART VI, LINE 12C OUR CONFLICT OF INTEREST POLICY WHICH HAS BEEN APPROVED BY THE BOARD IS PROVIDED TO ALL BOARD MEMBERS, OFFICERS AND MANAGEMENT STAFF. THEY ARE REQUIRED TO COMPLETE AND SIGN THE POLICY STATEMENT REQUIRING THAT PERSONS COMPLY WITH THE DISCLOSURE REQUIREMENTS AND VOTING AND MEMBERSHIP PROHIBITIONS SET IN THE POLICY. AS PART OF THIS POLICY, THEY ARE REQUIRED TO COMPLETE AND SIGN A CONFLICT OF INTEREST QUESTIONNAIRE. THIS QUESTIONNAIRE REQUIRES THAT PERSONS LISTED ABOVE IDENTIFY AND DISCLOSE ALL AFFILIATIONS OR INTERESTS WITH FACILITIES THEY OR IMMEDIATE FAMILY MEMBERS HAVE A RELATIONSHIP WITH. THESE QUESTIONNAIRES ARE REVIEWED BY THE CEO. THE CFO REVIEWS THE CEO'S COMPLETED QUESTIONNAIRE. OUR CONFLICT OF INTEREST POLICY ADDRESSES DUTIES TO DISCLOSE FINANCIAL INTERESTS, DUTY TO DISCLOSE RELATIONSHIPS WITH CERTAIN FACILITIES AND PROCEDURES FOR DETERMINING WHETHER A POTENTIAL CONFLICT OF INTEREST EXISTS. FURTHER, IF A POTENTIAL CONFLICT OF INTEREST IS IDENTIFIED, OUR POLICY ADDRESSES PROCEDURES FOR PRESENTING THE FACTS, INVESTIGATION OF POTENTIAL CONFLICTS BY A DISINTERESTED PERSON OR COMMITTEE AND A DECISION PROCESS TO DETERMINE IF THE TRANSACTION IS IN THE BEST INTEREST OF GCRBC, FOR GCRBC'S OWN BENEFIT, FAIR AND REASONABLE TO GCRBC AND/OR IN THE BEST INTEREST OF THE WELFARE OF THE COMMUNITY. OUR POLICY DEFINES POTENTIAL VIOLATIONS OF THE POLICY SUCH AS FAILURE TO DISCLOSE. THE POLICY DEFINES RECORDS OF PROCEDURES THAT CONTAIN IDENTIFIED CONFLICTS OF INTEREST, VOTING PROHIBITIONS AND RECORDS OF VOTING BY INDIVIDUAL BOARD MEMBERS. IF A PERSON HAS FAILED TO DISCLOSE AN ACTUAL OR POSSIBLE CONFLICT OF INTEREST, AN INVESTIGATION IS PERFORMED BY MANAGEMENT OR THE BOARD. IF IT IS FOUND THAT A PERSON HAS IN FACT FAILED TO DISCLOSE AN ACTUAL OR POSSIBLE CONFLICT OF INTEREST, MANAGEMENT OR THE BOARD, AS APPROPRIATE, WILL TAKE CORRECTIVE ACTION UP TO AND INCLUDING TERMINATION OF EMPLOYMENT OR DISMISSAL FROM THE BOARD. FORM 990, PART VI, LINES 15A & 15B ALL EXECUTIVE COMPENSATION IS REVIEWED AND APPROVED BY THE COMPENSATION COMMITTEE AND THE BOARD. COMPENSATION AMOUNTS ARE DETERMINED BASED ON INDEPENDENT SURVEYS AND COMPARABLE DATA TO ORGANIZATIONS OUR SIZE FOR NON-PROFITS, OTHER BLOOD CENTERS, AND GENERAL INDUSTRY. THIS PROCESS WAS LAST UNDERTAKEN FROM DECEMBER 2014 THROUGH JANUARY 2015. ALL OTHER MANAGEMENT POSITIONS' (DIRECTORS) COMPENSATION ARE BASED ON COMPENSATION REVIEWS PERFORMED BY OUR HUMAN RESOURCES DEPARTMENT. THE HR DEPARTMENT OBTAINS INDEPENDENT SURVEYS FOR THESE POSITIONS AND OTHER COMPARABLE DATA TO DETERMINE THEIR RECOMMENDATION OF THE COMPENSATION. ALL SALARY RECOMMENDATIONS ARE REVIEWED AND APPROVED BY THE EXECUTIVES. THIS PROCESS WAS LAST UNDERTAKEN FROM DECEMBER 2014 THROUGH FEBRUARY 2015. Form 990, Part VI, Line 19 PROCESS FOR MAKING DOCUMENTS AVAILABLE TO THE PUBLIC ALL GOVERNING DOCUMENTS, CONFLICTS OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. TAX FORM 990 AND 990-T (IF APPLICABLE) ARE ALSO AVAILABLE UPON REQUEST AND ARE ALSO AVAILABLE VIA GUIDESTAR'S WEBSITE. OUR WEBSITE HAS A LINK TO THE GUIDESTAR WEBSITE. BLOOD CORPORATION OF AMERICA 1400 LA CONCHA LANE HOUSTON TX 77054 740247034 INACTIVE TX GCRBC C Corp 0 0 1.00000 true false false false false false false false false false false false false false false false false false false false